MPB-1734

· MegaPro Biomedical Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MPB-1734, covering 2025-11-03 to 2025-11-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]